You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
疫苗股顯著回落 三葉草(02197.HK)及騰盛(02137.HK)急吐11%-17%
恆指現報20,883,續吐240點或1.1%,成交額944億元。 市場關注內地疫情發展。然而,疫苗股今天跟隨大市顯著回落,尤其是騰盛博藥-B(02137.HK)扭四連升,股價由逾四個月高位回落,最低見11.46元,現報11.62元,回吐17%,成交5,130萬股(昨天成交急增至9,872萬創上市新高)。 三葉草生物(02197.HK)也終止連日升勢,最低見4.1元(剛為10天線),現報4.14元,回吐11%,成交增至2,202萬股;開拓藥物(09939.HK)回吐6.3%報17.22元;康希諾(06185.HK)跌5.7%報73.5元;復星醫藥(02196.HK)續跌6.2%報30.2元。歌禮製藥-B(01672.HK)續跌3.6%報3.76元。國藥(01099.HK)續跌2.4%報19.22元。至於藍籌藥明生物(02269.HK)四連跌,最低見73.75元,現報74.4元,續跌3.4%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account